Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:NVAX News 24 November 2025 - 31 January 2026

Novavax stock drops 6% into the weekend as Pfizer Matrix‑M cash and earnings clock loom

Novavax stock drops 6% into the weekend as Pfizer Matrix‑M cash and earnings clock loom

Novavax shares fell 6.4% to $8.85 at Friday’s close, underperforming the broader market. Trading volume topped 5 million shares, above the 50-day average. Investors are watching for updates on partner-driven cash, including a $30 million upfront payment expected in Q1 2026 from a license deal. Novavax delayed its profitability target to 2028 and projects 2026 adjusted revenue of $185–$205 million.
31 January 2026
····
Pfizer stock price edges up — what PFE investors are watching after vaccine policy shifts

Pfizer stock price edges up — what PFE investors are watching after vaccine policy shifts

Pfizer shares closed up 0.8% at $26.10 Thursday, trading between $25.75 and $26.31. The gain followed news of a non-exclusive deal with Novavax for access to its Matrix‑M adjuvant, worth $30 million upfront. U.S. officials have reversed universal vaccine recommendations, shifting to “shared clinical-decision-making.” Pfizer CEO Albert Bourla blamed policy rhetoric for falling vaccination rates.
23 January 2026
···
Pfizer (PFE) stock edges up as ViiV exit cash and Novavax vaccine-tech pact grab attention

Pfizer (PFE) stock edges up as ViiV exit cash and Novavax vaccine-tech pact grab attention

Pfizer shares rose 0.8% to $25.73 Wednesday after the company agreed to exit its ViiV Healthcare stake, with Shionogi paying $1.875 billion and raising its holding to 21.7%. Pfizer also secured rights to Novavax’s Matrix-M adjuvant for $30 million upfront. Both deals await regulatory clearance and do not guarantee near-term earnings growth. Investors await Pfizer’s Q4 results on Feb. 3.
21 January 2026
····
NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

Data and news current as of 7 December 2025. NVAX stock price now: where Novavax stands in December 2025 Novavax, Inc. (NASDAQ: NVAX) closed on Friday, 5 December 2025 at $6.91 per share, giving the vaccine maker a market value of around $1.1 billion.Novavax Investor Relations+1 Over the last year, NVAX has slipped roughly 20%, according to data from Investing.com and other market trackers.Investing.com+1 That’s modest compared with its longer-term collapse: Simply Wall St calculates that Novavax shares are down about 94% over the past five years, even after a flurry of recent milestones.Simply Wall St+1 Key trading stats as
7 December 2025
Novavax Stock (NVAX) on November 24, 2025: Price, Sanofi Deal, Shah Capital Pressure and What It All Means for Investors

Novavax Stock (NVAX) on November 24, 2025: Price, Sanofi Deal, Shah Capital Pressure and What It All Means for Investors

All figures current as of the U.S. market close on Friday, November 21, 2025. NVAX will next trade when markets reopen on Monday, November 24, 2025. Quick snapshot for NVAX heading into November 24, 2025 Novavax stock price today: where NVAX stands Going into Monday, November 24, 2025, Novavax shares are coming off a choppy stretch. In other words, NVAX is trading like a classic high‑beta biotech: small‑cap, volatile, and highly sensitive to news about regulation, partnerships and activist investors. Latest Novavax news investors need to know 1. Q3 2025 earnings: revenue beat, but losses widen and profitability delayed On
24 November 2025
·

Stock Market Today

Singapore Exchange (SGX) share price slips into weekend — what S68 investors are watching next week

Singapore Exchange (SGX) share price slips into weekend — what S68 investors are watching next week

8 February 2026
Singapore, Feb 8, 2026, 15:10 SGT — Market closed. Singapore Exchange Ltd (S68.SI) shares ended down 0.4% at S$17.57 on Friday, trimming 7 Singapore cents, in the last session before the weekend break. About 5.0 million shares changed hands, and the stock finished roughly 3% below its 52-week high, according to market data. (Investing.com) With the market shut on Sunday, the next move may hinge less on a single company headline and more on what the week says about Singapore’s growth pulse and risk appetite. SGX is a straight-through play on trading activity: more turnover and hedging usually means more
Keppel stock price in focus as broker lifts target and dividend clock ticks

Keppel stock price in focus as broker lifts target and dividend clock ticks

8 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, outperforming the Straits Times Index. UOB Kay Hian raised its target price to S$13.23 after Keppel announced a 38% higher FY2025 dividend, with key dates set for April. The M1 sale remains delayed pending regulatory approval. Investors await updates on asset sales and dividend plans when trading resumes Monday.
Go toTop